Evaluate the Efficacy of the Axl inhibitor Bemcentinib in the 5xFAD mouse model of Alzheimer’s Disease

Guyin Chen, Gizem Ozturk, Sílvia Porta, Virginia M‐Y Lee · 2025

Read Evaluate the Efficacy of the Axl inhibitor Bemcentinib in the 5xFAD mouse model of Alzheimer’s Disease by Guyin Chen, Gizem Ozturk, Sílvia Porta, Virginia M‐Y Lee (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710453.txt.

Description

Guyin Chen and co-authors test a drug against Alzheimer's disease in mice in a 2025 study. The drug, bemcentinib, blocks Axl, a receptor found on microglia, the immune cells of the brain. Active microglia release signals that can harm neurons and may aid plaque build-up.

The test used 5xFAD mice, which form amyloid plaques and show overactive microglia like human disease. The team checked whether the drug blocked Axl activity in the brain. They also judged whether that block changed disease signs. A treatment aimed at microglia, not at plaques alone, would open a new route in Alzheimer's care. Mouse results here are an early step.

Catalog record

CREATORGuyin Chen, Gizem Ozturk, Sílvia Porta, Virginia M‐Y Lee
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE2 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11710453

Browse the full library · About the Tower of Babel